Anxiolytic-like actions of leaves of Casimiroa edulis (Rutaceae) in male Wistar rats

Journal of Ethnopharmacology

Volumn 93, Issue 1, 2004, Pages 93-98

  Molina Hernandez M ^a   Tellez Alcantara N P ^a   Perez Garcia J ^a   Lopez, J I Olivera ^b   Jaramillo, M Teresa ^b  

^a UNIVERSIDAD VERACRUZANA   (Mexico)

^b UNIVERSIDAD AUTÓNOMA METROPOLITANA   (Mexico)

Author keywords

Anxiolytic like action; Casimiroa edulis; Elevated plus maze; Forced swimming task; Open field test

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CASIMIROA EDULIS EXTRACT; DESIPRAMINE; DIAZEPAM; HERBACEOUS AGENT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CASIMIROA EDULIS; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; FORCED SWIMMING TEST; LOCOMOTION; MALE; MAZE TEST; MEDICINAL PLANT; NONHUMAN; OPEN FIELD BEHAVIOR; RAT; RAT STRAIN; RUTACEAE; TASK PERFORMANCE; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; CASIMIROA; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MAZE LEARNING; PLANT EXTRACTS; PLANT LEAVES; RATS; RATS, WISTAR;

EID: 2942616987     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2004.03.039     Document Type: Article

References (35)

1. Bhattacharya S.K., Mitra S.K. Anxiolytic activity of Panax ginseng roots: an experimental study. Journal of Ethnopharmacology. 34:1991;87-92
2. Borsini F., Meli A. Is the forced swim test a suitable model for revealing antidepressant activity? Psychopharmacology. 94:1988;147-160
3. Cano, L., 1997. Flora medicinal de Veracruz. I. In: Anonymous (Ed.), Inventario Etnobotánico. Universidad Veracruzana. México.
4. Cervo L., Grignaschi G., Samanin R. 8-Hydroxy-2-(di-n-propylamino) tetralin, a selective serotonin-1A receptor agonist, reduces the immobility of rats in the forced swimming test by acting on the nucleus raphe dorsalis. European Journal of Pharmacology. 158:1988;53-59
5. Crawley J.N. Exploratory behavior models of anxiety in mice. Neuroscience and Biobehavioral Reviews. 9:1985;37-44
6. Ernst E. Herb-drug interactions: potentially important but woefully under-researched. European Journal Clinical Pharmacology. 56:2000;523-524
7. Fisher C.E., Hughes R.N. Effects of diazepam and cyclohexyladenosine on open-field behavior in rats perinatally exposed to caffeine. Life Sciences. 58:1996;701-709
8. Goldberg H.L. Benzodiazepine and nonbenzodiazepine anxiolytics. Psychopathology. 17:1984;45-55
9. Handley S.L., McBlane J.W. An assessment of the elevated X maze for studying anxiety and anxiety-modulating drugs. Journal of Pharmacology and Toxicology Methods. 29:1993;129-135
10. Hasenöhrl R.U., Nichau C.H., Frisch C.H., De Souza M.A., Huston M.A., Mattern C.M., Hacher R. Anxiolytic-like effect of combined extracts of Zingiber officinale and Ginkgo biloba in the elevated plus-maze. Pharmacology, Biochemistry and Behavior. 53:1996;271-275
11. Hasenöhrl R.U., Topic B., Frisch C., Hacker R., Mattern C.M., Huston J.P. Dissociation between anxiolytic and hypomnestic effects for combined extracts of Zingiber officinale and Ginkgo biloba, as opposed to diazepam. Pharmacology, Biochemistry and Behavior. 59:1998;527-535
12. Hogg S. A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacology, Biochemistry and Behavior. 54:1996;21-30
13. Jaiswal A.K., Bhattacharya S.K., Acharya S.B. Anxiolytic activity of Azadirachta indica leaf extract in rats. Indian Journal of Experimental Biology. 32:1994;489-491
14. Kasture V.S., Deshmukh V.K., Chopde C.T. Anxiolytic and anticonvulsive activity of Sesbania grandiflora leaves in experimental animals. Phytotherapy Research. 16:2000;455-460
15. Kendall P.C. Empirically supported psychological therapies. Journal of Consulting Clinical Psychology. 66:1998;3-6
16. Kostowski W., Oyr W., Jarbe T.U., Archer T. 5-Hydroxytryptamine-1A receptor agonists in animal models of depression and anxiety. Pharmacology and Toxicology. 71:1992;24-30
17. Martínez, M., 1996. Las Plantas Medicinales de México. Botas, México.
18. Menard J., Treit D. Effects of centrally administered anxiolytic compounds in animal models of anxiety. Neurosciences and Biobehavioral Reviews. 23:1999;591-613
19. Molina M., Téllez-Alcántara N.P. Antidepressant-like actions of pregnancy, and progesterone in Wistar rats forced to swim. Psychoneuroendocrinology. 26:2001;479-491
20. National Institutes of Health, 1996. Guide for the Care and Use of Laboratory Animals. National Institutes of Health, National Academy Press, Washington, OC, USA.
21. Navarro A., Bastidas B.E., García J., García P., Garzón P. Anticonvulsant activity of Casimiroa edulis in comparison to phenytoin and phenobarbital. Journal of Ethnopharmacology. 45:1995;199-206
22. Norquist G.S., Regier D.A. The epidemiology of psychiatric disorders and the de facto mental health care system. Annual Reviews in Medicine. 47:1996;473-479
23. Porsolt R.O., Anton G., Blavet N., Jalfre M. Behavioural despair in rats: a new model sensitive to antidepressant treatments. European Journal of Pharmacology. 47:1978;379-391
24. Rodgers R.J., Johnson N.J.T. Cholecystokinin and anxiety: promises and pitfalls. Critical Reviews in Neurobiology. 9:1995;345-369
25. Rodgers R.J., Dalvi A. Anxiety, defense and the elevated plus-maze. Neurosciences and Biobehavioral Reviews. 21:1997;801-810
26. Stock H., Foradori C., Ford K., Wilson M.A. A lack of tolerance to the anxiolytic effects of diazepam on the plus-maze: a comparison of male and female rats. Psychopharmacology. 147:2000;362-370
27. Thongsaard W., Deachapunya C., Pongsakorn S., Boyd E., Bennett G., Marsden A. Barakol: a potential anxiolytic extracted from Cassia siamea. Pharmacology, Biochemistry and Behavior. 53:1996;753-758
28. Van Der Meersch-Mougeot V., Da Rocha M., Monier C., Diquiet B., Puech A.J., Thiébot M.H. Benzodiazepines reverse the anti-immobility effect of antidepressant in the forced swimming test in mice. Neuropharmacology. 32:1993;439-446
29. Viola H., Wolfman C., Levi De Stein M., Wasowski C., Peña C., Medina J.H., Paladini A.C. Isolation of pharmacologically active benzodiazepine receptor ligands from Tilia tomentosa (Tiliaceae). Journal of Ethnopharmacology. 44:1994;47-53
30. Viola H., Wasowski C., Levi De Stein M., Wolfman C., Silveira R., Dajas F., Medina J.H., Paladini A.C. Apigenin, a component of Matricaria recutita flowers, is a central benzodiazepine receptor-ligand with anxiolytic effects. Planta Medica. 61:1995;213-216
31. Wieland S., Lucki l. Antidepressant-like activity of 5HT-1A agonists measured with the forced swim test. Psychopharmacology. 101:1990;497-504
32. Wiklund, I.K., Mattsson, L.A., Lindgren, R., Limoni, C., 1999. Effects of a standardized ginseng extract on quality of life and physiological parameters in symptomatic postmenopausal women: a double-blind, placebo-controlled trial. International Journal of Clinical Pharmaceutical Research 19, 89-99.
33. Wolfman C., Viola H., Paladini A.C., Dajas F., Medina J.H. Possible anxiolytic effects of chrysin, a central benzodiazepine receptor ligand isolated from Passiflora coerulea. Pharmacology, Biochemistry and Behavior. 47:1994;1-4
34. Wong A.H., Smith M., Boon H.S. Herbal remedies in psychiatric practice. Archives in General Psychiatry. 55:1998;1033-1044
35. Zolla C. Traditional medicine in Latin America, with particular reference to México. Journal Ethnopharmacology. 2:1980;37-41